Related Experiment Videos
[New targets of anticancer drugs and their pathways]
1Research Division of Pharmacology, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.
Abstract:
This article reviews recent advances in apoptosis on the pathway inducing cancer cell to death, including Bcl-2 family pathway, NF-kappa B pathway, P13K/Akt pathway, Rb gene and p53 gene, especially the targets of anticancer drug in these pathways. It could be useful for the anticancer drug design and estimate. Furthermore, those cancer/testis antigen gene products are potential targets for antigen-specific immunotherapy of carcinoma.
Insights
This review covers cancer cell death pathways like Bcl-2 family and p53, highlighting drug targets for new anticancer drug design and immunotherapy strategies.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Context:
- Apoptosis, or programmed cell death, is crucial in cancer development and progression.
- Understanding apoptosis pathways is key to developing effective cancer therapies.
Purpose:
- To review recent advances in apoptosis research relevant to cancer.
- To identify molecular targets within these pathways for anticancer drug development and immunotherapy.
Summary:
- Discusses key apoptosis pathways including the Bcl-2 family, NF-kappa B, P13K/Akt, Rb gene, and p53 gene.
- Highlights specific molecular targets within these pathways that are targeted by current and potential anticancer drugs.
- Explores cancer/testis antigen gene products as targets for antigen-specific cancer immunotherapy.
Impact:
- Provides insights for anticancer drug design and evaluation.
- Identifies potential targets for novel immunotherapeutic approaches against carcinoma.